Yolanda Sanz, the coordinator of MyNewGut spoke at the OECD Workshop on “The Microbiome, Diet and Health: Assessing Gaps in Science and Innovation” in Brussels, on the 30-31 of May 2016. The workshop will convene scientific, policy, and industry leaders involved in the fields of human microbial and food research, food and drug regulation, and nutraceutical production.
Part 2 of the MyNewGut podcast is out!
This time around we asked Dr Joan Vermeiren who works in the Nutrition Science Group of Cargill to introduce their work in Work Package 7 of the MyNewGut project:
At the 15th ICC International Cereal and Bread Congress, Dr Jan Willem van der Kamp of MyNewGut partner TNO lectured in the Healthgrain Forum Session on “Cereal and Other Fibres, Definition, Dietary Recommendations, Health Effects and New Perspectives”. He presented recent insights in the beneficial effects of cereal fibres (more than of other fibres) for risk reduction for heart diseases, diabetes type-2 and colon cancer, and for inducing short-term mental benefits such as reduction of stress. His lecture, was with two others awarded as excellent presentation of the congress.
Ted Dinan MD, PhD, Department of Psychiatry and APC Microbiome Institute, University College, Cork presented at the 3rd Microbiome R&D and Business Collaboration Forum: Europe in London. 11th – 12th April 2016. Below is a summary of his presentation on microbes and the gut brain axis:
Evidence is accumulating to suggest that gut microbes may be involved in neural development and function, both peripherally in the enteric nervous system and centrally in the brain. There is an increasing and intense current interest in the role that gut bacteria play in maintaining the health of the host. Altogether the mass of intestinal bacteria represents a virtual inner organ with 100 times the total genetic material contained in all the cells in the human body.
Dr Sandrine Claus, Associate Professor of Integrative Metabolism at the University of Reading, UK answered a Q&A prior to her talk at the 3rd Microbiome R&D and Business Collaboration Forum: Europe in London. 11th – 12th April 2016.
What aspect of microbiome research are you focusing on at the moment?
The research performed in my group focuses on the exploration of the metabolic cross-talk between the gut microbiota and its host. Our projects therefore span across a wide range of issues, from investigation of host-pathogen interactions in broiler chicken to the role of bacteria in type 2 diabetes.
More specifically, we have just started to look at the influence of some milk-derived bioactive peptides on the gut microbial ecosystem, as this has been suggested as a potential mechanism associated with the development of diabetes and autism.